Skip to main content

East Bay biotech giant to cut 530 jobs, add 325 in restructuring

The biotech tools company, whose shareholders include BlackRock Inc., said the phased restructuring will cost $125 million to $130 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.